Compound used as RET kinase inhibitor and application thereof

The present invention belongs to the field of medical technology and specifically disclosed is a compound represented by formula (I'), or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and each symbol therein is as defined in the claims. The compound of the presen...

Full description

Saved in:
Bibliographic Details
Main Authors NIU, Chengshan, LIANG, Apeng, WU, Yusheng, LI, Jun, ZHENG, Maolin
Format Patent
LanguageEnglish
Published 27.01.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention belongs to the field of medical technology and specifically disclosed is a compound represented by formula (I'), or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and each symbol therein is as defined in the claims. The compound of the present invention may be used as a drug for regulating RET kinase activity or treating RET-related diseases, and has better pharmacokinetic properties.
Bibliography:Application Number: AU20200280699